Immunochina

OverviewSuggest Edit

Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. It provides treatments for a variety of malignant hematological tumors and solid tumors, including lymphocytic leukemia, non-Hodgkin's lymphoma, multiple myeloma, pancreatic cancer, lung cancer, and liver cancer.
TypePrivate
Founded2015
HQCN
Websiteimmunochina.com

Locations

Immunochina is headquartered in
China

Location Map

Latest Updates

Employees (est.) (Sept 2020)6(-14%)
Cybersecurity ratingAMore

Immunochina Office Locations

Immunochina has an office in
Show all (1)

Immunochina Financials and Metrics

Summary Metrics

Founding Date

2015

Immunochina total Funding

$28.1 m

Immunochina latest funding size

$20.60 m

Time since last funding

2 years ago

Immunochina investors

Immunochina's latest funding round in January 2019 was reported to be $20.6 m. In total, Immunochina has raised $28.1 m
Show all financial metrics

Immunochina Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Immunochina Online and Social Media Presence

Embed Graph

Immunochina Frequently Asked Questions

  • When was Immunochina founded?

    Immunochina was founded in 2015.

  • How many employees does Immunochina have?

    Immunochina has 6 employees.

  • Who are Immunochina competitors?

    Competitors of Immunochina include Divide & Conquer, Paradigm Diagnostics and Actuate Therapeutics.

  • Where are Immunochina offices?

    Immunochina has an office in.

  • How many offices does Immunochina have?

    Immunochina has 1 office.